Published in Proc Natl Acad Sci U S A on August 25, 2008
The influenza virus enigma. Cell (2009) 2.48
Structures of influenza A proteins and insights into antiviral drug targets. Nat Struct Mol Biol (2010) 2.31
Suppression of the antiviral response by an influenza histone mimic. Nature (2012) 2.18
Crystal structure of a human cleavage factor CFI(m)25/CFI(m)68/RNA complex provides an insight into poly(A) site recognition and RNA looping. Structure (2011) 1.82
Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J Virol (2010) 1.81
Induction and evasion of type I interferon responses by influenza viruses. Virus Res (2011) 1.59
The Protein Structure Initiative: achievements and visions for the future. F1000 Biol Rep (2012) 1.38
Influenza a virus polymerase is an integral component of the CPSF30-NS1A protein complex in infected cells. J Virol (2008) 1.35
Structural insights into phosphoinositide 3-kinase activation by the influenza A virus NS1 protein. Proc Natl Acad Sci U S A (2010) 1.34
Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-β transcription. Virology (2010) 1.26
The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV. J Virol (2009) 1.20
Emerging antiviral targets for influenza A virus. Trends Pharmacol Sci (2009) 1.18
A Closer Look at the NS1 of Influenza Virus. Viruses (2009) 1.15
The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins. J Virol (2011) 1.13
Virulence and genetic compatibility of polymerase reassortant viruses derived from the pandemic (H1N1) 2009 influenza virus and circulating influenza A viruses. J Virol (2011) 1.13
Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response. J Virol (2010) 1.13
Genomic and protein structural maps of adaptive evolution of human influenza A virus to increased virulence in the mouse. PLoS One (2011) 1.13
Structure of NS1A effector domain from the influenza A/Udorn/72 virus. Acta Crystallogr D Biol Crystallogr (2008) 1.10
A transient homotypic interaction model for the influenza A virus NS1 protein effector domain. PLoS One (2011) 1.07
Improved technologies now routinely provide protein NMR structures useful for molecular replacement. Structure (2011) 1.07
Evasion of influenza A viruses from innate and adaptive immune responses. Viruses (2012) 1.06
Recent progress in structure-based anti-influenza drug design. Drug Discov Today (2012) 1.06
Strong interferon-inducing capacity of a highly virulent variant of influenza A virus strain PR8 with deletions in the NS1 gene. J Gen Virol (2009) 1.04
Dimer interface of the effector domain of non-structural protein 1 from influenza A virus: an interface with multiple functions. J Biol Chem (2011) 1.03
Innate immune evasion strategies of influenza viruses. Future Microbiol (2010) 1.00
The influenza virus NS1 protein as a therapeutic target. Antiviral Res (2013) 0.99
Identification of RNA helicase A as a cellular factor that interacts with influenza A virus NS1 protein and its role in the virus life cycle. J Virol (2011) 0.96
The novel human influenza A(H7N9) virus is naturally adapted to efficient growth in human lung tissue. MBio (2013) 0.96
Delineating the structural blueprint of the pre-mRNA 3'-end processing machinery. Mol Cell Biol (2014) 0.96
Innate immunity to H5N1 influenza viruses in humans. Viruses (2012) 0.94
Structural biology of poly(A) site definition. Wiley Interdiscip Rev RNA (2011) 0.94
Identification of amino acid changes that may have been critical for the genesis of A(H7N9) influenza viruses. J Virol (2014) 0.93
X-ray structures of NS1 effector domain mutants. Arch Biochem Biophys (2009) 0.92
Genetically engineered, biarsenically labeled influenza virus allows visualization of viral NS1 protein in living cells. J Virol (2010) 0.92
Functions of the influenza A virus NS1 protein in antiviral defense. Curr Opin Virol (2015) 0.91
A single amino acid substitution in the novel H7N9 influenza A virus NS1 protein increases CPSF30 binding and virulence. J Virol (2014) 0.90
2009 pandemic H1N1 influenza virus causes disease and upregulation of genes related to inflammatory and immune responses, cell death, and lipid metabolism in pigs. J Virol (2011) 0.89
Self-association of lymphocytic choriomeningitis virus nucleoprotein is mediated by its N-terminal region and is not required for its anti-interferon function. J Virol (2012) 0.88
The influenza A virus protein NS1 displays structural polymorphism. J Virol (2014) 0.86
High yield production of influenza virus in Madin Darby canine kidney (MDCK) cells with stable knockdown of IRF7. PLoS One (2013) 0.86
SUMOylation affects the interferon blocking activity of the influenza A nonstructural protein NS1 without affecting its stability or cellular localization. J Virol (2013) 0.85
Differential effects of NS1 proteins of human pandemic H1N1/2009, avian highly pathogenic H5N1, and low pathogenic H5N2 influenza A viruses on cellular pre-mRNA polyadenylation and mRNA translation. J Biol Chem (2010) 0.84
Contribution of double-stranded RNA and CPSF30 binding domains of influenza virus NS1 to the inhibition of type I interferon production and activation of human dendritic cells. J Virol (2012) 0.84
Structure and function of pre-mRNA 5'-end capping quality control and 3'-end processing. Biochemistry (2014) 0.84
To die or not to die? Lessons from lesion mimic mutants. Front Plant Sci (2015) 0.83
New small-molecule drug design strategies for fighting resistant influenza A. Acta Pharm Sin B (2015) 0.82
Genetic dynamic analysis of the influenza A H5N1 NS1 gene in China. PLoS One (2014) 0.82
Shutoff of Host Gene Expression in Influenza A Virus and Herpesviruses: Similar Mechanisms and Common Themes. Viruses (2016) 0.81
(19)F NMR reveals multiple conformations at the dimer interface of the nonstructural protein 1 effector domain from influenza A virus. Structure (2014) 0.81
Genetic characterisation of novel, highly pathogenic avian influenza (HPAI) H5N6 viruses isolated in birds, South Korea, November 2016. Euro Surveill (2017) 0.81
Expression of non-structural-1A binding protein in lung epithelial cells is modulated by miRNA-548an on exposure to influenza A virus. Virology (2013) 0.80
Analysis of influenza A virus NS1 dimer interfaces in solution by pulse EPR distance measurements. J Phys Chem B (2014) 0.80
Conservation of a crystallographic interface suggests a role for β-sheet augmentation in influenza virus NS1 multifunctionality. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.79
A Second RNA-Binding Site in the NS1 Protein of Influenza B Virus. Structure (2016) 0.79
Critical Role of the PA-X C-Terminal Domain of Influenza A Virus in Its Subcellular Localization and Shutoff Activity. J Virol (2016) 0.78
Inhibition of type I interferon production via suppressing IKK-gamma expression: a new strategy for counteracting host antiviral defense by influenza A viruses? J Proteome Res (2011) 0.78
Structural Basis for a Novel Interaction between the NS1 Protein Derived from the 1918 Influenza Virus and RIG-I. Structure (2015) 0.78
Mutations within the conserved NS1 nuclear export signal lead to inhibition of influenza A virus replication. Virol J (2014) 0.78
NS1 Protein Amino Acid Changes D189N and V194I Affect Interferon Responses, Thermosensitivity, and Virulence of Circulating H3N2 Human Influenza A Viruses. J Virol (2017) 0.77
Generation of replication-proficient influenza virus NS1 point mutants with interferon-hyperinducer phenotype. PLoS One (2014) 0.77
Regulation of interferon-β by MAGI-1 and its interaction with influenza A virus NS1 protein with ESEV PBM. PLoS One (2012) 0.77
Mutations Designed by Ensemble Defect to Misfold Conserved RNA Structures of Influenza A Segments 7 and 8 Affect Splicing and Attenuate Viral Replication in Cell Culture. PLoS One (2016) 0.76
Virtual screening of potential inhibitors from TCM for the CPSF30 binding site on the NS1A protein of influenza A virus. J Mol Model (2014) 0.76
hnRNP A2/B1 interacts with influenza A viral protein NS1 and inhibits virus replication potentially through suppressing NS1 RNA/protein levels and NS1 mRNA nuclear export. Virology (2013) 0.76
Cleavage and polyadenylation specificity factor 30: An RNA-binding zinc-finger protein with an unexpected 2Fe-2S cluster. Proc Natl Acad Sci U S A (2016) 0.76
NS1 Protein Mutation I64T Affects Interferon Responses and Virulence of Circulating H3N2 Human Influenza A Viruses. J Virol (2016) 0.76
Fluorescence-Activated Cell Sorting-Based Analysis Reveals an Asymmetric Induction of Interferon-Stimulated Genes in Response to Seasonal Influenza A Virus. J Virol (2015) 0.76
H5N1 influenza virulence, pathogenicity and transmissibility: what do we know? Future Virol (2015) 0.75
Comparative influenza protein interactomes identify the role of plakophilin 2 in virus restriction. Nat Commun (2017) 0.75
Appearance of L90I and N205S Mutations in Effector Domain of NS1 Gene of pdm (09) H1N1 Virus from India during 2009-2013. Adv Virol (2014) 0.75
Amino acid substitution K186E in the canine influenza virus H3N8 NS1 protein restores its ability to inhibit host gene expression. J Virol (2017) 0.75
Influenza A Virus Virulence Depends on Two Amino Acids in the N-Terminal Domain of Its NS1 Protein To Facilitate Inhibition of the RNA-Dependent Protein Kinase PKR. J Virol (2017) 0.75
Molecular features of influenza A (H1N1)pdm09 prevalent in Mexico during winter seasons 2012-2014. PLoS One (2017) 0.75
Structure-Guided Functional Annotation of the Influenza A Virus NS1 Protein Reveals Dynamic Evolution of the p85β-Binding Site During Circulation in Humans. J Virol (2017) 0.75
Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science (2001) 18.43
Selenomethionyl proteins produced for analysis by multiwavelength anomalous diffraction (MAD): a vehicle for direct determination of three-dimensional structure. EMBO J (1990) 8.46
Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol Cell (1998) 5.60
Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol (2005) 5.28
Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J Virol (2002) 4.87
Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A (2002) 4.26
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proc Natl Acad Sci U S A (2000) 3.95
Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol (2007) 3.53
The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A (2006) 3.50
Induction of IRF-3/-7 kinase and NF-kappaB in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells (2001) 3.42
Recognition of the mRNA AU-rich element by the zinc finger domain of TIS11d. Nat Struct Mol Biol (2004) 3.39
Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology (2006) 3.00
Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A (2006) 2.63
Robotic cloning and Protein Production Platform of the Northeast Structural Genomics Consortium. Methods Enzymol (2005) 2.54
The 30-kD subunit of mammalian cleavage and polyadenylation specificity factor and its yeast homolog are RNA-binding zinc finger proteins. Genes Dev (1997) 2.46
Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein. Nat Struct Biol (1997) 2.41
A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology (2007) 2.30
A novel RNA-binding motif in influenza A virus non-structural protein 1. Nat Struct Biol (1997) 2.16
The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target. J Virol (2006) 2.05
The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA (2001) 1.94
Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J Gen Virol (2007) 1.84
Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique. Proc Natl Acad Sci U S A (2002) 1.78
The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells. J Virol (2007) 1.75
X-ray structure of influenza virus NS1 effector domain. Nat Struct Mol Biol (2006) 1.74
Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode. Biochemistry (2004) 1.72
Structure of an avian influenza A virus NS1 protein effector domain. Virology (2008) 1.50
SH3 binding motif 1 in influenza A virus NS1 protein is essential for PI3K/Akt signaling pathway activation. J Virol (2007) 1.47
Specific binding of influenza A virus NS1 protein to the virus minus-sense RNA in vitro. J Gen Virol (1992) 1.46
Influenza virus virulence and its molecular determinants. Adv Virus Res (2005) 1.44
Conserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B viruses. J Biol Chem (2007) 1.40
Influenza virus inhibits cleavage of the HSP70 pre-mRNAs at the polyadenylation site. Virology (1999) 1.29
Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics. J Virol (2004) 1.28
Binding of influenza A virus NS1 protein to the inter-SH2 domain of p85 suggests a novel mechanism for phosphoinositide 3-kinase activation. J Biol Chem (2007) 1.08
Consistent blind protein structure generation from NMR chemical shift data. Proc Natl Acad Sci U S A (2008) 6.76
Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity. J Biol Chem (2004) 6.55
Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer (2005) 6.05
Evaluating protein structures determined by structural genomics consortia. Proteins (2007) 5.45
Protein NMR recall, precision, and F-measure scores (RPF scores): structure quality assessment measures based on information retrieval statistics. J Am Chem Soc (2005) 4.43
Protein production and purification. Nat Methods (2008) 3.97
The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature (2006) 3.88
Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A (2005) 3.74
The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A (2006) 3.50
The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc Natl Acad Sci U S A (2004) 3.16
Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology (2006) 3.00
NMR structure determination for larger proteins using backbone-only data. Science (2010) 3.00
PubNet: a flexible system for visualizing literature derived networks. Genome Biol (2005) 2.89
Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition. J Mol Biol (2008) 2.88
Inhibition of bacterial RNA polymerase by streptolydigin: stabilization of a straight-bridge-helix active-center conformation. Cell (2005) 2.88
High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations. Proc Natl Acad Sci U S A (2008) 2.82
Aptamer mediated siRNA delivery. Nucleic Acids Res (2006) 2.77
Members of the large Maf transcription family regulate insulin gene transcription in islet beta cells. Mol Cell Biol (2003) 2.64
Cold-shock induced high-yield protein production in Escherichia coli. Nat Biotechnol (2004) 2.62
Robotic cloning and Protein Production Platform of the Northeast Structural Genomics Consortium. Methods Enzymol (2005) 2.54
CASD-NMR: critical assessment of automated structure determination by NMR. Nat Methods (2009) 2.50
Principles for designing ideal protein structures. Nature (2012) 2.50
Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA. EMBO J (2002) 2.41
Mechanism of activation for transcription factor PhoB suggested by different modes of dimerization in the inactive and active states. Structure (2005) 2.39
UNC119 is required for G protein trafficking in sensory neurons. Nat Neurosci (2011) 2.38
Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem (2005) 2.38
Reduced-dimensionality NMR spectroscopy for high-throughput protein resonance assignment. Proc Natl Acad Sci U S A (2002) 2.36
Automatic target selection for structural genomics on eukaryotes. Proteins (2004) 2.34
Outcome of a workshop on archiving structural models of biological macromolecules. Structure (2006) 2.32
The protein target list of the Northeast Structural Genomics Consortium. Proteins (2004) 2.31
Structures of influenza A proteins and insights into antiviral drug targets. Nat Struct Mol Biol (2010) 2.31
In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine). J Med Chem (2005) 2.31
A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology (2007) 2.30
Structural basis of transcription initiation. Science (2012) 2.23
NMR data collection and analysis protocol for high-throughput protein structure determination. Proc Natl Acad Sci U S A (2005) 2.09
Outcome of a workshop on applications of protein models in biomedical research. Structure (2009) 2.05
The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target. J Virol (2006) 2.05
Single base-resolution methylome of the silkworm reveals a sparse epigenomic map. Nat Biotechnol (2010) 2.03
The RNA polymerase "switch region" is a target for inhibitors. Cell (2008) 1.96
Assignment validation software suite for the evaluation and presentation of protein resonance assignment data. J Biomol NMR (2004) 1.95
Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors. Prog Biophys Mol Biol (2005) 1.93
Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J Virol (2007) 1.92
The high-throughput protein sample production platform of the Northeast Structural Genomics Consortium. J Struct Biol (2010) 1.90
ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc Natl Acad Sci U S A (2010) 1.89
HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel site. ACS Chem Biol (2006) 1.83
Determination of solution structures of proteins up to 40 kDa using CS-Rosetta with sparse NMR data from deuterated samples. Proc Natl Acad Sci U S A (2012) 1.83
The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro. J Virol (2003) 1.80
A topology-constrained distance network algorithm for protein structure determination from NOESY data. Proteins (2006) 1.79
Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir. Nat Struct Mol Biol (2004) 1.78
Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique. Proc Natl Acad Sci U S A (2002) 1.78
Understanding the physical properties that control protein crystallization by analysis of large-scale experimental data. Nat Biotechnol (2009) 1.78
Solution NMR structure of the iron-sulfur cluster assembly protein U (IscU) with zinc bound at the active site. J Mol Biol (2004) 1.76
Preparation of protein samples for NMR structure, function, and small-molecule screening studies. Methods Enzymol (2011) 1.75
An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth. Spine J (2006) 1.75
The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells. J Virol (2007) 1.75
Assessment of heavy metal pollution in wetland soils from the young and old reclaimed regions in the Pearl River Estuary, South China. Environ Pollut (2010) 1.75
Structural and biochemical studies identify tobacco SABP2 as a methyl salicylate esterase and implicate it in plant innate immunity. Proc Natl Acad Sci U S A (2005) 1.73
Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode. Biochemistry (2004) 1.72
An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis. Mol Cell Biol (2005) 1.67
A de novo protein binding pair by computational design and directed evolution. Mol Cell (2011) 1.65
Short homologous sequences are strongly associated with the generation of chimeric RNAs in eukaryotes. J Mol Evol (2008) 1.63
Two-dimensional infrared spectra reveal relaxation of the nonnucleoside inhibitor TMC278 complexed with HIV-1 reverse transcriptase. Proc Natl Acad Sci U S A (2007) 1.61
Novel leverage of structural genomics. Nat Biotechnol (2007) 1.57
Mining the structural genomics pipeline: identification of protein properties that affect high-throughput experimental analysis. J Mol Biol (2004) 1.57
Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells. J Virol (2009) 1.55
Crucial role of CA cleavage sites in the cap-snatching mechanism for initiating viral mRNA synthesis. EMBO J (2003) 1.55
Structural and molecular interactions of CCR5 inhibitors with CCR5. J Biol Chem (2006) 1.55
Prenatal exposure to multiple toxic heavy metals and neonatal neurobehavioral development in Shanghai, China. Neurotoxicol Teratol (2011) 1.55
Pbx/Meis deficiencies demonstrate multigenetic origins of congenital heart disease. Circ Res (2008) 1.54
Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design. Nucleic Acids Res (2008) 1.54